Deutsche Bank
STLN

Deutsche Bank’s Starling Oncology STLN Stock Holding History

Deutsche Bank’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
75,937
+20,015
+36% +$84.1K ﹤0.01% 2872
2026
Q1 		$172K Buy
55,922
+8,074
+17% +$24.8K ﹤0.01% 3065
2025
Q4 		$170K Sell
47,848
-40,633
-46% -$151K ﹤0.01% 3090
2025
Q3 		$309K Buy
88,481
+86,846
+5,312% +$298K ﹤0.01% 2833
2025
Q2 		$3.35K Buy
+1,635
New +$4.09K ﹤0.01% 3552
2024
Q2 		– Sell
-9,435
Closed -$14.9K – 3696
2024
Q1 		$14.9K Hold
9,435
– – ﹤0.01% 3517
2023
Q4 		$19.2K Hold
9,435
– – ﹤0.01% 3497
2023
Q3 		$13.2K Sell
9,435
-10,936
-54% -$11.3K ﹤0.01% 3539
2023
Q2 		$11.2K Sell
20,371
-572
-3% -$303 ﹤0.01% 3642
2023
Q1 		$14.2K Buy
20,943
+5,571
+36% +$7.11K ﹤0.01% 3747
2022
Q4 		$25.4K Buy
15,372
+230
+2% +$646 ﹤0.01% 3735
2022
Q3 		$70K Buy
15,142
+5,695
+60% +$33.5K ﹤0.01% 3485
2022
Q2 		$48K Buy
+9,447
New +$68.8K ﹤0.01% 3768
2021
Q4 		– Sell
-500,000
Closed -$4.97M – 4403
2021
Q3 		$4.97M Sell
500,000
-80,308
-14% -$797K ﹤0.01% 1501
2021
Q2 		$5.77M Sell
580,308
-16,334
-3% -$164K ﹤0.01% 1439
2021
Q1 		$5.94M Sell
596,642
-100,386
-14% -$1.07M ﹤0.01% 1454
2020
Q4 		$7.53M Sell
697,028
-100,000
-13% -$1.03M ﹤0.01% 1161
2020
Q3 		$8.27M Hold
797,028
– – 0.01% 1040
2020
Q2 		$8.01M Buy
+797,028
New +$7.93M 0.01% 1072

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank's STLN Position: Q2 2026 in Review

Deutsche Bank increased its Starling Oncology (STLN) stake by 36% in Q2 2026, buying an estimated $84.1K and bringing the position to 75,937 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

Deutsche Bank first reported a position in STLN in Q2 2020 and has held it in 19 quarters since. The position peaked at $8.27M in Q3 2020. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Deutsche Bank held 75,937 shares of Starling Oncology worth $412K as of Q2 2026.
  • Deutsche Bank bought 20,015 Starling Oncology shares in Q2 2026, an estimated $84.1K.
  • Starling Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2872 holding.
  • Deutsche Bank first reported a position in Starling Oncology in Q2 2020 and has held it in 19 quarters since.
  • Deutsche Bank's Starling Oncology position peaked at $8.27M in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.